Sapiens Q2 revenue up 3.5%, beats expectations

Reuters
Aug 13, 2025
Sapiens <a href="https://laohu8.com/S/QTWO">Q2</a> revenue up 3.5%, beats expectations

Overview

  • Sapiens Q2 2025 rev rises 3.5% yr/yr, beating analysts' expectations

  • Adjusted EPS and net income for Q2 beat consensus

  • Co completed acquisitions of Advantage Go and Candella, boosting P&C and Life segments

Outlook

  • Sapiens expects acquisitions to strengthen P&C and Life growth

  • Company aims to accelerate cloud adoption and expand globally

  • Sapiens focuses on platform innovation and cross-selling for growth

  • Company sees growth catalysts in Life & Annuities expansion

Result Drivers

  • STRATEGIC PRIORITIES - Co executed strategic priorities by securing new deals and strengthening customer relationships in Life, P&C, and Reinsurance segments, per CEO Roni Al-Dor

  • ACQUISITIONS - Completed acquisitions of Advantage Go and Candella to strengthen P&C and Life growth

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Beat

$141.60 mln

$140 mln (4 Analysts)

Q2 Adjusted EPS

Beat

$0.34

$0.32 (4 Analysts)

Q2 EPS

$0.25

Q2 Adjusted Net Income

Beat

$19.30 mln

$18.10 mln (4 Analysts)

Q2 Adjusted Operating Income

Beat

$23.10 mln

$21.60 mln (4 Analysts)

Q2 Adjusted Gross Margin

45.8%

Q2 Adjusted Gross Profit

$64.80 mln

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 2 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the software peer group is "buy."

  • Wall Street's median 12-month price target for Sapiens International Corporation NV is $31.00, about 4.8% above its August 12 closing price of $29.50

  • The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 18 three months ago

Press Release: ID:nPn89NWJca

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10